MDV3100-08: A phase 1 study evaluating the safety and pharmacokinetics of enzalutamide plus fulvestrant in women with advanced hormone receptor-positive breast cancer Meeting Abstract


Authors: Elias, A. D.; Burris, H. A.; Patel, M. R.; Schwartzberg, L. S.; Richer, J. K.; Kavalerchik, E.; Stopatschinskaja, S.; Gibbons, J.; Markova, D.; Steinberg, J. L.; Traina, T. A.
Abstract Title: MDV3100-08: A phase 1 study evaluating the safety and pharmacokinetics of enzalutamide plus fulvestrant in women with advanced hormone receptor-positive breast cancer
Meeting Title: 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 76
Issue: 4 Suppl.
Meeting Dates: 2015 Dec 8-12
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2016-02-15
Language: English
ACCESSION: WOS:000375622403445
DOI: 10.1158/1538-7445.sabcs15-p1-16-05
PROVIDER: wos
Notes: Meeting Abstract: P1-16-05 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Tiffany A Traina
    250 Traina